ID   HYAS2_RAT               Reviewed;         552 AA.
AC   O35776;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   29-MAY-2024, entry version 135.
DE   RecName: Full=Hyaluronan synthase 2;
DE            EC=2.4.1.212 {ECO:0000250|UniProtKB:Q92819};
DE   AltName: Full=Hyaluronate synthase 2;
DE   AltName: Full=Hyaluronic acid synthase 2;
DE            Short=HA synthase 2;
GN   Name=Has2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Sakaguchi K., Midura R.J.;
RT   "Molecular cloning of rat hyaluronan synthase 2 and regulation of its
RT   expression in a rat osteoblastic cell line.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes the addition of GlcNAc or GlcUA monosaccharides to
CC       the nascent hyaluronan polymer. Therefore, it is essential to
CC       hyaluronan synthesis a major component of most extracellular matrices
CC       that has a structural role in tissues architectures and regulates cell
CC       adhesion, migration and differentiation (By similarity). This is one of
CC       three isoenzymes responsible for cellular hyaluronan synthesis and it
CC       is particularly responsible for the synthesis of high molecular mass
CC       hyaluronan (By similarity). {ECO:0000250|UniProtKB:P70312,
CC       ECO:0000250|UniProtKB:Q92819}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[hyaluronan](n) + UDP-N-acetyl-alpha-D-glucosamine = H(+) + N-
CC         acetyl-beta-D-glucosaminyl-(1->4)-[hyaluronan](n) + UDP;
CC         Xref=Rhea:RHEA:20465, Rhea:RHEA-COMP:12583, Rhea:RHEA-COMP:12585,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57705, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:132153, ChEBI:CHEBI:132154; EC=2.4.1.212;
CC         Evidence={ECO:0000250|UniProtKB:Q92819};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20466;
CC         Evidence={ECO:0000250|UniProtKB:Q92819};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-acetyl-beta-D-glucosaminyl-(1->4)-[hyaluronan](n) + UDP-
CC         alpha-D-glucuronate = [hyaluronan](n+1) + H(+) + UDP;
CC         Xref=Rhea:RHEA:12528, Rhea:RHEA-COMP:12585, Rhea:RHEA-COMP:12587,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:132153, ChEBI:CHEBI:132154; EC=2.4.1.212;
CC         Evidence={ECO:0000250|UniProtKB:Q92819};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12529;
CC         Evidence={ECO:0000250|UniProtKB:Q92819};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- PATHWAY: Glycan biosynthesis; hyaluronan biosynthesis.
CC       {ECO:0000250|UniProtKB:Q92819}.
CC   -!- SUBUNIT: Homodimer; dimerization promotes enzymatic activity. Forms
CC       heterodimer with HAS3. Forms heterodimer with HAS1.
CC       {ECO:0000250|UniProtKB:Q92819}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q92819};
CC       Multi-pass membrane protein {ECO:0000255}. Endoplasmic reticulum
CC       membrane {ECO:0000250|UniProtKB:Q92819}; Multi-pass membrane protein
CC       {ECO:0000255}. Vesicle {ECO:0000250|UniProtKB:Q92819}. Golgi apparatus
CC       membrane {ECO:0000250|UniProtKB:Q92819}; Multi-pass membrane protein
CC       {ECO:0000255}. Lysosome {ECO:0000250|UniProtKB:Q92819}. Note=Travels
CC       from endoplasmic reticulum (ER), Golgi to plasma membrane and either
CC       back to endosomes and lysosomes, or out into extracellular vesicles.
CC       Post-translational modifications control HAS2 trafficking.
CC       {ECO:0000250|UniProtKB:Q92819}.
CC   -!- PTM: Phosphorylation at Thr-328 is essential for hyaluronan synthase
CC       activity. {ECO:0000250|UniProtKB:Q92819}.
CC   -!- PTM: O-GlcNAcylation at Ser-221 increases the stability of HAS2 and
CC       plasma membrane localization. {ECO:0000250|UniProtKB:Q92819}.
CC   -!- PTM: Ubiquitination at Lys-190; this ubiquitination is essential for
CC       hyaluronan synthase activity and homo- or hetero-oligomerization. Can
CC       also be poly-ubiquitinated. Deubiquitinated by USP17L22/USP17 and USP4.
CC       USP17L22/USP17 efficiently removes 'Lys-63'- and 'Lys-48'-linked
CC       polyubiquitin chains, whereas USP4 preferentially removes
CC       monoubiquitination and, partially, both 'Lys-63'- and 'Lys-48'-linked
CC       polyubiquitin chain. {ECO:0000250|UniProtKB:Q92819}.
CC   -!- SIMILARITY: Belongs to the NodC/HAS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF008201; AAB63209.1; -; mRNA.
DR   RefSeq; NP_037285.1; NM_013153.1.
DR   AlphaFoldDB; O35776; -.
DR   SMR; O35776; -.
DR   STRING; 10116.ENSRNOP00000006517; -.
DR   CAZy; GT2; Glycosyltransferase Family 2.
DR   GlyCosmos; O35776; 1 site, No reported glycans.
DR   GlyGen; O35776; 1 site.
DR   PhosphoSitePlus; O35776; -.
DR   PaxDb; 10116-ENSRNOP00000006517; -.
DR   Ensembl; ENSRNOT00000006517.5; ENSRNOP00000006517.4; ENSRNOG00000004854.5.
DR   Ensembl; ENSRNOT00055037174; ENSRNOP00055030261; ENSRNOG00055021708.
DR   Ensembl; ENSRNOT00060005727; ENSRNOP00060004182; ENSRNOG00060003489.
DR   Ensembl; ENSRNOT00065025052; ENSRNOP00065019609; ENSRNOG00065015133.
DR   GeneID; 25694; -.
DR   KEGG; rno:25694; -.
DR   AGR; RGD:2781; -.
DR   CTD; 3037; -.
DR   RGD; 2781; Has2.
DR   eggNOG; KOG2571; Eukaryota.
DR   GeneTree; ENSGT00390000010337; -.
DR   HOGENOM; CLU_029695_3_0_1; -.
DR   InParanoid; O35776; -.
DR   OMA; KSATYVW; -.
DR   OrthoDB; 1361850at2759; -.
DR   PhylomeDB; O35776; -.
DR   TreeFam; TF332506; -.
DR   BRENDA; 2.4.1.212; 5301.
DR   Reactome; R-RNO-2142850; Hyaluronan biosynthesis and export.
DR   UniPathway; UPA00341; -.
DR   PRO; PR:O35776; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000004854; Expressed in quadriceps femoris and 10 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:1903561; C:extracellular vesicle; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0044853; C:plasma membrane raft; ISO:RGD.
DR   GO; GO:0050501; F:hyaluronan synthase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0036302; P:atrioventricular canal development; ISS:UniProtKB.
DR   GO; GO:0060349; P:bone morphogenesis; ISO:RGD.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; ISO:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISO:RGD.
DR   GO; GO:0036120; P:cellular response to platelet-derived growth factor stimulus; ISO:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISO:RGD.
DR   GO; GO:0090500; P:endocardial cushion to mesenchymal transition; ISS:UniProtKB.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0085029; P:extracellular matrix assembly; ISS:UniProtKB.
DR   GO; GO:0045226; P:extracellular polysaccharide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0030213; P:hyaluronan biosynthetic process; IEP:UniProtKB.
DR   GO; GO:0030212; P:hyaluronan metabolic process; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:1900127; P:positive regulation of hyaluronan biosynthetic process; IDA:RGD.
DR   GO; GO:0051549; P:positive regulation of keratinocyte migration; IDA:RGD.
DR   GO; GO:0010838; P:positive regulation of keratinocyte proliferation; IMP:RGD.
DR   GO; GO:1900625; P:positive regulation of monocyte aggregation; ISO:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IMP:RGD.
DR   GO; GO:0035810; P:positive regulation of urine volume; IEP:UniProtKB.
DR   GO; GO:1901201; P:regulation of extracellular matrix assembly; IMP:RGD.
DR   GO; GO:0070295; P:renal water absorption; IEP:UniProtKB.
DR   GO; GO:0001570; P:vasculogenesis; ISS:UniProtKB.
DR   CDD; cd06434; GT2_HAS; 1.
DR   InterPro; IPR001173; Glyco_trans_2-like.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR22913; HYALURONAN SYNTHASE; 1.
DR   PANTHER; PTHR22913:SF7; HYALURONAN SYNTHASE 2; 1.
DR   Pfam; PF03142; Chitin_synth_2; 1.
DR   Pfam; PF00535; Glycos_transf_2; 1.
DR   SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Endoplasmic reticulum; Glycoprotein; Glycosyltransferase;
KW   Golgi apparatus; Isopeptide bond; Lysosome; Membrane; Phosphoprotein;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   CHAIN           1..552
FT                   /note="Hyaluronan synthase 2"
FT                   /id="PRO_0000197175"
FT   TOPO_DOM        1..11
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        12..32
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        33..45
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        46..66
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        67..374
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        375..395
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        396..402
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        403..423
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        424..429
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        430..450
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        451..475
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        476..496
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        497..510
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        511..531
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        532..552
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         110
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92819"
FT   MOD_RES         328
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92819"
FT   CARBOHYD        221
FT                   /note="O-linked (GlcNAc) serine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92819"
FT   CROSSLNK        190
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q92819"
SQ   SEQUENCE   552 AA;  63534 MW;  1DCAA244E3A4E9BC CRC64;
     MHCERFLCVL RIIGTTLFGV SLLLGITAAY IVGYQFIQTD NYYFSFGLYG AFLASHLIIQ
     SLFAFLEHRK MKKSLETPIK LNKTVALCIA AYQEDPDYLR KCLQSVKRLT YPGIKVVMVI
     DGNSDDDLYM MDIFSEVMGR DKSVTYIWKN NFHERGPGET EESHKESSQH VTQLVLSNKS
     ICIMQKWGGK REVMYTAFRA LGRSVDYVQV CDSDTMLDPA SSVEMVKVLE EDPMVGGVGG
     DVQILNKYDS WISFLSSVRY WMAFNIERAC QSYFGCVQCI SGPLGMYRNS LLHEFVEDWY
     NQEFMGNQCS FGDDRHLTNR VLSLGYATKY TARSKCLTET PIEYLRWLNQ QTRWSKSYFR
     EWLYNAMWFH KHHLWMTYEA VITGFFPFFL IATVIQLFYR GKIWNILLFL LTVQLVGLIK
     SSFASCLRGN IVMVFMSLYS VLYMSSLLPA KMFAIATINK AGWGTSGRKT IVVNFIGLIP
     VSVWFTILLG GVIFTIYKES KKPFSESKQT VLIVGTLIYA CYWVVLLTLY VVLINKCGRR
     KKGQQYDMVL DV
//
